Effect of rosiglitazone/ramipril on preclinical vasculopathy in newly diagnosed, untreated diabetes and IGT patients: 1-year randomised, double-blind, placebo-controlled study

Author: Rahman Sayeeda   Ismail Aziz   Ismail Shaiful   Naing Nyi   Abdul Rahman Abdul  

Publisher: Springer Publishing Company

ISSN: 0031-6970

Source: European Journal of Clinical Pharmacology, Vol.63, Iss.8, 2007-08, pp. : 733-741

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content